Skip to main content

Table 3 Thrombogram parameters and Pd-MP levels in all patients and in patients on chemotherapy according to the time since the diagnosis (less than 6 months or more)

From: Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

  All patients (n = 62) Patients on chemotherapy (n = 41)
  0-6 months (n = 27) >6 months (n = 35) 0-6 months (n = 20) >6 months (n = 21)
MRI (nM/min) 160 ± 60* 153 ± 48 161 ± 55* 148 ± 52
Peak (nM) 353 ± 92* 336 ± 70* 362 ± 73* 324 ± 74
ETP (nM.min) 1593 ± 340* 1483 ± 332 1627 ± 335* 1402 ± 327
Pd-MP (/μL) 10098 ± 7057 9946 ± 9175 10054 ± 7769 9026 ± 7469
Pd-MP/PS + (/μL) 9731 ± 6821 9671 ± 8841 9695 ± 7488 8793 ± 7265
PPL (sec) 43,9 ± 10,8 43,3 ± 10,1 43,3 ± 12,3 44,7 ± 10,8
  1. Values are mean ± sd. *p < 0,05 versus >6 months.